AIMING AT 2025 PROJECTED REVENUE RANGE OF $1.6 TO $2.0 BILLION AS COMMERCIAL TEAMS STRENGTHENED FOUNDATION OF SEASONAL VACCINE FRANCHISE (ADDS DROPPED PERIOD '2025')
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.